Loading…

Heparin-induced vasodilation in human hand veins

Objective To investigate whether heparin produces vasodilation in human veins and to explore the underlying mechanisms. Methods Eleven healthy volunteers were studied with the dorsal hand vein compliance technique. Dose‐response curves to heparin and enoxaparin were generated. Dose‐response curves t...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 1999-09, Vol.66 (3), p.232-238
Main Authors: Tangphao, Oranee, Chalon, Stephan, Moreno, Heitor J., Abiose, Ademola K., Blaschke, Terrence F., Hoffman, Brian B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To investigate whether heparin produces vasodilation in human veins and to explore the underlying mechanisms. Methods Eleven healthy volunteers were studied with the dorsal hand vein compliance technique. Dose‐response curves to heparin and enoxaparin were generated. Dose‐response curves to heparin were also constructed before and after heparin was infused with the nitric oxide synthase inhibitor NG‐monomethyl‐l‐arginine (L‐NMMA) or combined histamine H1‐ and H2‐receptor blockade. Results Heparin but not enoxaparin caused significant dose‐dependent relaxation with an average apparent maximal response (at an infusion rate of 20 IU/min) of 47% ± 23%. L‐NMMA attenuated heparin‐induced relaxation (P < .001). The combination of H1‐ and H2‐receptor antagonists attenuated heparin‐induced relaxation to a lesser extent (P < .05). Heparin‐induced relaxation decreased by 52%, 73%, and 35% in the presence of L‐NMMA, indomethacin (INN, indometacin) plus L‐NMMA, and combined H1‐ and H2‐receptor blockade, respectively. Conclusion Heparin is an endothelium‐dependent venodilator in humans. The mechanism of heparin‐induced relaxation involves an increased availability of nitric oxide, possibly partially related to local release of histamine. Clinical Pharmacology & Therapeutics (1999) 66, 232–238; doi:
ISSN:0009-9236
1532-6535
DOI:10.1016/S0009-9236(99)70030-5